Condition: Heart Disease Congenital · Neurodevelopmental Disorder · Sponsor: Nantes University Hospital
Congenital heart defects (CHD), as the leading cause of birth defects, affect 12 million people globally and approximately 41,000 newborns each year in Europe. CHD presents a significant public health concern due to its association with high morbidity and mortality rates across the lifespan. Over 50% of infants born with critical CHD will develop neurodevelopmental disorders (NDD), requiring specialized care and impacting their quality of life. NDDs, involving early and persistent disruptions in cognitive, emotional, and behavioral development due to abnormal brain development, are highly variable. They may impact language, learning, motor skills, intellectual efficiency, social cognition, attention, memory, and executive functions, often accompanied by psychosocial difficulties. These hidden disabilities constitute the primary long-term sequelae of CHD, surpassing even cardiovascular complications in impact, and affect children who often undergo multiple cardiac surgeries during early childhood. NDDs are associated not only with complex CHDs but also with simpler CHDs that are repaired in early childhood and considered 'cured.' The origin of CHD-associated NDDs remains largely unknown. While few genetic or environmental causes have been identified, recent research suggests a possible common origin linking heart malformations and neurodevelopmental abnormalities. The CATAMARAN neonatal cohort project aims to detect developmental delays associated with CHD as early as six mon…
This description comes directly from the study's public registry record.
Alban Baruteau · +33 2 40 08 77 42 · albanelouen.baruteau@chu-nantes.fr
Always discuss trial participation with your own doctor first.
| Nantes University Hospital | Nantes, Loire Atlantique, France | Recruiting |
| CHU de Bordeaux | Bordeaux, France | Recruiting |
| APHP - Antoine Béclère | Clamart, France | Recruiting |
| Hôpital Marie Lannelongue | Le Plessis-Robinson, France | Recruiting |
| AP-HM | Marseille, France | Recruiting |
| AP-HP Necker | Paris, France | Not Yet Recruiting |
| CHU de Toulouse | Toulouse, France | Not Yet Recruiting |
| CHRU Tours | Tours, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06690151